Surrozen Inc.

AI Score

XX

Unlock

0.02
-0.00 (-0.50%)
At close: Apr 04, 2025, 1:20 PM
-0.50%
Bid 0.02
Market Cap 39.48M
Revenue (ttm) n/a
Net Income (ttm) n/a
EPS (ttm) -5.695
PE Ratio (ttm) n/a
Forward PE n/a
Analyst n/a
Ask 0.02
Volume 2,066
Avg. Volume (20D) 19,855.548
Open 0.02
Previous Close 0.02
Day's Range 0.02 - 0.02
52-Week Range 0.02 - 0.02
Beta 0.74

About SRZNW

Surrozen, Inc., a biotechnology company, discovers and develops drug candidates to selectively modulate the Wnt pathway for tissue repair and regeneration. It is developing tissue-specific antibodies to engage the body's existing biological repair mechanisms with potential application across various disease areas, including diseases of the intestine, liver, retina, cornea, lung, kidney, cochlea, skin, pancreas, and central nervous system. Its pro...

Industry Biotechnology
Sector Healthcare
IPO Date Aug 10, 2021
Employees 42
Stock Exchange NASDAQ
Ticker Symbol SRZNW
Full Company Profile
No News article available yet